10349206|t|[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication].
10349206|a|Barbiturates can produce psychological and physical dependence and produce a withdrawal syndrome on the second to fourth day after the drug is suspended. Symptoms include anxiety, restlessness, insomnia, rhythmic intention tremor, dizziness, seizures, and psychosis. If the syndrome is not recognized and correctly treated, hyperthermia, circulatory failure, and death may ensue. Although barbiturates are less frequently used nowadays, they are employed in combination with other drugs in many medications used for the treatment of headache. We report the case of a 54-year-old woman who developed a barbiturate abstinence syndrome when she suspended self-administration of a drug containing butalbital. The patient had been using barbiturates, 900 mg/die, for 2+ years for persistent headache. She was admitted to the hospital because of seizures, hallucinations and delirium not controlled by benzodiazepine and phenothiazine administration. Her symptoms resolved after parenteral phenobarbital administration.
10349206	1	32	Barbiturate withdrawal syndrome	Disease	MESH:D013375
10349206	72	80	headache	Disease	MESH:D006261
10349206	94	106	Barbiturates	Chemical	MESH:D001463
10349206	171	190	withdrawal syndrome	Disease	MESH:D013375
10349206	265	272	anxiety	Disease	MESH:D001007
10349206	274	286	restlessness	Disease	MESH:D011595
10349206	288	296	insomnia	Disease	MESH:D007319
10349206	298	323	rhythmic intention tremor	Disease	MESH:D014202
10349206	325	334	dizziness	Disease	MESH:D004244
10349206	336	344	seizures	Disease	MESH:D012640
10349206	350	359	psychosis	Disease	MESH:D011618
10349206	418	430	hyperthermia	Disease	MESH:D005334
10349206	432	451	circulatory failure	Disease	MESH:D012769
10349206	457	462	death	Disease	MESH:D003643
10349206	483	495	barbiturates	Chemical	MESH:D001463
10349206	627	635	headache	Disease	MESH:D006261
10349206	673	678	woman	Species	9606
10349206	695	706	barbiturate	Chemical	MESH:C032232
10349206	707	726	abstinence syndrome	Disease	MESH:D009357
10349206	787	797	butalbital	Chemical	MESH:C004470
10349206	803	810	patient	Species	9606
10349206	826	838	barbiturates	Chemical	MESH:D001463
10349206	880	888	headache	Disease	MESH:D006261
10349206	934	942	seizures	Disease	MESH:D012640
10349206	944	958	hallucinations	Disease	MESH:D006212
10349206	963	971	delirium	Disease	MESH:D003693
10349206	990	1004	benzodiazepine	Chemical	MESH:D001569
10349206	1009	1022	phenothiazine	Chemical	MESH:C031637
10349206	1078	1091	phenobarbital	Chemical	MESH:D010634
10349206	Negative_Correlation	MESH:D001463	MESH:D006261
10349206	Positive_Correlation	MESH:D001463	MESH:D014202
10349206	Negative_Correlation	MESH:D001569	MESH:D003693
10349206	Positive_Correlation	MESH:D001463	MESH:D003693
10349206	Positive_Correlation	MESH:D001463	MESH:D007319
10349206	Positive_Correlation	MESH:D001463	MESH:D011595
10349206	Positive_Correlation	MESH:D001463	MESH:D006212
10349206	Positive_Correlation	MESH:D001463	MESH:D013375
10349206	Negative_Correlation	MESH:C031637	MESH:D003693
10349206	Positive_Correlation	MESH:D001463	MESH:D001007
10349206	Positive_Correlation	MESH:D001463	MESH:D004244
10349206	Positive_Correlation	MESH:D001463	MESH:D005334
10349206	Positive_Correlation	MESH:D001463	MESH:D012640
10349206	Positive_Correlation	MESH:D001463	MESH:D012769
10349206	Negative_Correlation	MESH:D010634	MESH:D003693
10349206	Negative_Correlation	MESH:D010634	MESH:D006212
10349206	Positive_Correlation	MESH:D001463	MESH:D011618
10349206	Negative_Correlation	MESH:D010634	MESH:D012640
10349206	Positive_Correlation	MESH:C004470	MESH:D009357

